A M Jullien - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A M Jullien

Showing results (21-30 of 36) with videos related to

Pageof 4

Sort By:

Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|October 1, 1990

[Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?]A M Jullien, A M Courouce, M Maniez, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|January 3, 2001

The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance systemT Calvez, M Biou, D Costagliola, et al.

Presse Medicale (Paris, France : 1983)|September 14, 1985

[Association of Biermer's anemia with chronic myeloid leukemia. A case report]A P Blanc, G Cebe, A M Jullien-Depradeux, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1993

Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmissionA M Jullien, A M Couroucé, V Massari, et al.

Transfusion|May 1, 1991

HTLV-I transmission and myelopathy induced by blood transfusionC Fretz, D Jaulmes, G Jordan, et al.

Infusionstherapie Und Transfusionsmedizin|June 1, 1993

[Comments on HIV antigen screening of blood donors]K Baumgarten, P Chiewsilp, R Gilcher, et al.

Presse Medicale (Paris, France : 1983)|November 28, 1987

[Prevalence of anti-HIV antibodies in immunoglobulins recipients]C Brémard-Oury, A M Couroucé, M Badillet, et al.

Lancet (London, England)|March 27, 1993

Testing for HCV-RNA in commercial intravenous immunoglobulinsJ J Lefrère, M Mariotti, C Trepo, et al.

Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|May 1, 1991

[Investigation of a transfusion contaminated by HTLV-I virus]C Fretz, D Jaulmes, A Nicod, et al.

La Nouvelle Presse Medicale|September 24, 1977

[High dose combination chemotherapy followed by autologous bone marrow transplantation in a case of acute myelocytic leukemia (author's transl)]N C Gorin, J Stachowiak, F Hirsch-Marie, et al.

Pageof 4

Search research articles

Showing results (21-30 of 36) with videos related to

Sort By:

Pageof 4

Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|October 1, 1990

[Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?]A M Jullien, A M Courouce, M Maniez, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|January 3, 2001

The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance systemT Calvez, M Biou, D Costagliola, et al.

Presse Medicale (Paris, France : 1983)|September 14, 1985

[Association of Biermer's anemia with chronic myeloid leukemia. A case report]A P Blanc, G Cebe, A M Jullien-Depradeux, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1993

Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmissionA M Jullien, A M Couroucé, V Massari, et al.

Transfusion|May 1, 1991

HTLV-I transmission and myelopathy induced by blood transfusionC Fretz, D Jaulmes, G Jordan, et al.

Infusionstherapie Und Transfusionsmedizin|June 1, 1993

[Comments on HIV antigen screening of blood donors]K Baumgarten, P Chiewsilp, R Gilcher, et al.

Presse Medicale (Paris, France : 1983)|November 28, 1987

[Prevalence of anti-HIV antibodies in immunoglobulins recipients]C Brémard-Oury, A M Couroucé, M Badillet, et al.

Lancet (London, England)|March 27, 1993

Testing for HCV-RNA in commercial intravenous immunoglobulinsJ J Lefrère, M Mariotti, C Trepo, et al.

Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|May 1, 1991

[Investigation of a transfusion contaminated by HTLV-I virus]C Fretz, D Jaulmes, A Nicod, et al.

La Nouvelle Presse Medicale|September 24, 1977

[High dose combination chemotherapy followed by autologous bone marrow transplantation in a case of acute myelocytic leukemia (author's transl)]N C Gorin, J Stachowiak, F Hirsch-Marie, et al.

Pageof 4